Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI

Prepand to the content

Tempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously founded Groupon, debuted on Nasdaq on Friday, rising about 15% on the opening.  The company priced its IPO on Thursday at $37 apiece, at the top of its $35 to $37 price range, raising nearly $411 million at a fully diluted […]

© 2024 TechCrunch. All rights reserved. For personal use only.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.